Abstract:BackgroundBRAF V600E mutation was proved to be associated with thyroid cancer. Papillary thyroid carcinoma (PTC) with positive BRAF mutation might have a more aggressive behavior. We investigated the correlation of the contrast-enhanced ultrasound (CEUS) features with BRAF 600VE in PTC.MethodsThe medical records of 1,199 patients with 1,315 nodules who underwent CEUS prior to fine needle aspiration (FNA) from January 2016 to March 2018 were retrospectively reviewed. The features of their enhancement were assessed from eight aspects: degree of enhancement, method of enhancement, homogeneity of enhancement, completeness of enhancement, boundary of the enhanced lesions, shape of the enhanced lesions, size of the enhanced lesions, and wash out period of the enhanced lesions. The patients then examined for the BRAF V600E mutation using specimens obtained from FNA.ResultsBRAF mutations were found in 888 of 1,315 nodules. The CEUS features were significantly different between BRAF-positive and BRAF-negative nodules. The BRAF mutation positive nodules were more often with larger size, hypo-enhancement, centripetal enhancement, inhomogeneous enhancement, complete enhancement, blurred boundary, irregular shape, and with wash out period at preoperative CEUS than those without BRAF mutations (P<0.001). However, no significant correlation was showed in Spearman's rank correlation between the CEUS features and BRAF mutation, except for degree of enhancement, method pattern of enhancement, and completeness of complete enhancement. Multivariate analysis showed that centripetal (OR: 1.465, 95% CI: 1.129-1.903) and no significant enhancement (OR: 0.790, 95% CI: 0.639-0.977) were predictive for the presence of BRAF mutations. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of no significant enhancement and centripetal enhancement of CEUS for predicting BRAF mutation were 68.3%, 40.0%, 91.6%, 11.7%, and 72.4%, 35.1%, 37.8%, 70.0%, respectively.ConclusionsOur study indicated that preoperative thyroid nodule characteristics on CEUS might serve as a useful tool to BRAF mutation in PTC.

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer with BRAF V600E Mutation.

Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma

Associations of the BRAF V600E Mutation with Sonographic Features in Patients with Papillary Thyroid Carcinoma

Use of the BRAF V600E Mutation in Fine-Needle Aspirations of Thyroid Nodules

The Features of Contrast Enhanced Ultrasound and BRAF V600E in Papillary Thyroid Carcinoma.

Conventional Ultrasound, Immunohistochemical Factors and BRAFV600E Mutation in Predicting Central Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma.

Relationship Between BRAF V600E Gene Mutation and the Clinical and Pathologic Characteristics of Papillary Thyroid Microcarcinoma.

Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features

Brafv600e Mutation in Papillary Thyroid Microcarcinoma: A Meta-Analysis

Role of Ultrasonographic Features and Quantified BRAFV600E Mutation in Lymph Node Metastasis in Chinese Patients with Papillary Thyroid Carcinoma

Relationship between BRAF V600E mutation, cervical lymph node metastases and extrathyroidal ;extension in papillary thyroid carcinoma

Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients

Associations of BRAF V600E, Clinical Pathology and Imaging Factors with the Recurrence Rate of Papillary Thyroid Microcarcinoma

BRAFV600E mutation and NIS expression in papillary thyroid carcinomas

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients

Association of BRAF(V600E) Mutation with Ultrasonographic Features and Clinicopathologic Characteristics of Papillary Thyroid Microcarcinoma: A Retrospective Study of 116 Cases

Integrating BRAFV600E mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma

Association Between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and Without Hashimoto's Thyroiditis.

Analysis of 179 BRAFV600E mutation in papillary thyroid carcinoma patients

BRAF V600E Mutation and Its Association with Clinicopathological Features of Papillary Thyroid Microcarcinoma: A Meta-Analysis

The association between BRAF V600E mutation and pathological features in PTC